IMPACT Medicom

IMPACT Medicom

By IMPACT MedicomScience
Download on the App Store

IMPACT Medicom episodes

  • Treatment of Advanced Urothelial Carcinoma – A Discussion of EV-301

    Welcome to our podcast episode on the treatment of urothelial carcinoma. In this episode, hosted by Anna Christofides, we  discuss updated results of the Phase 3 EV-301 trial, presented at ASCO 2022, that examined the efficacy and safety of Enfortumab Vedotin, or EV, versus chemotherapy in patients with previously treated locally advanced or metastatic urothelial carcinoma. 

    Our Guest:
    Our guest for this episode is Dr Nimira Alimohamed, Medical Oncologist and Clinical Associate Professor of Medicine at the University of Calgary and Medical Oncologist at the Tom Baker Cancer Centre in Calgary, Alberta. 

    This podcast episode was sponsored by Seagen Canada.

    If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com 

    13 min
  • Immunotherapy for Cervical Cancer

    In this episode, we discuss immunotherapy treatment and biomarker testing for metastatic cervical cancer. 

    Our Guest:
    Dr. James Bentley is a Professor and Head of the Department of Obstetrics and Gynecology at Dalhousie University, Halifax, Canada. Dr. Bentley is Past President of the International Federation of Cervical Pathology and Colposcopy (IFCPC) and the Society of Canadian Colposcopists (SCC). He is also Past-President of the Society of Gynecologic Oncology of Canada (GOC). He serves on numerous national and provincial committees involved with cervical cancer screening and gynecological cancer. 

    This podcast episode was sponsored by Merck Canada.

    If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com 

    19 min
  • Immunotherapy in HNSCC Series: Ep 3 - Role of the Medical Oncologist

    In this episode of IMPACT Medicom’s podcast series on immunotherapies in Head and Neck Squamous Cell Carcinoma, we discuss the medical oncologist’s role in managing patients with HNSCC, and how immunotherapies fit in to their practice.

    Our Guest:
    Dr. Martin Smoragiewicz is a Medical Oncologist at the Odette Cancer Centre, part of Sunnybrook Health Sciences Centre in Toronto, Ontario. His clinical expertise is in Genitourinary and Head & Neck cancers and his research focuses on improving therapeutics, with a special interest in immunotherapy. Dr. Smoragiewicz is the principal investigator on numerous clinical trials, and the lead for Head & Neck clinical trials at the Odette Cancer Centre.

    This podcast episode was sponsored by Merck Canada.

    If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com 

    13 min
  • Precision Medicine in Oncology: Ep.11. Selection and use of PARP inhibitors for first-line maintenance treatment in ovarian cancer

    Welcome to episode 11 of our Precision Medicine in Oncology series. In this episode, we discuss the development of a pan-Canadian consensus paper on the selection and use of PARP inhibitors for first-line maintenance treatment in ovarian cancer.

    Our Guest:
    Our guest for this episode is Dr. Anna Tinker, Medical Oncologist at BC Cancer in Vancouver, Canada. Dr. Tinker is also a Clinical Associate Professor in the Department of Medicine at the University of British Columbia.

    This podcast episode was sponsored by Merck Canada.

    If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com 

    16 min
  • Immunotherapy in HNSCC Series: Ep 2 - Perspectives from Surgical Oncology

    Welcome to the second episode of IMPACT Medicom’s podcast series on Immunotherapy in Head and Neck Squamous Cell Carcinomas (HNSCC). This episode includes a discussion of:

    • The role of the surgical oncologist in managing patients with HNSCC
    • How immunotherapy fits into to the surgical oncologist's practice 

     
    Our Guest:
    Our guest is Dr. Antoine Eskander, a head and neck surgical oncologist at Sunnybrook Health Sciences Centre and Assistant professor in the department of otolaryngology at the University of Toronto. He is also an adjunct scientist at the Institute for Clinical Evaluative Sciences. 

    This podcast episode was sponsored by Merck Canada.

    If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com

    15 min
  • Immunotherapy in HNSCC Series: Ep 1 - PD-L1 testing

    Welcome to the first episode of IMPACT Medicom’s podcast series on Immunotherapy in Head and Neck Squamous Cell Carcinomas. This episode includes a discussion of:

    • The role of the pathologist in the management of head and neck cancers 
    • PD-L1 testing as a predictive biomarker for immunotherapy in HNSCC
    • Improving the testing process for PD-L1

     
    Our Guest:
    Our guest is Dr. Matthew Cecchini, Pathologist in the Department of Pathology and Laboratory Medicine at London Health Sciences Centre and  Assistant Professor at Western University in London Ontario Canada. Dr. Cecchini  specializes in pulmonary, head and neck, and molecular pathology. His research interests include the application of digital and machine learning tools in pathology. 



    This podcast episode was sponsored by Merck Canada.

    If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com

    13 min
  • Triple Negative Breast Cancer: Immunotherapies and Biomarkers

    In this episode, we discuss the treatment of triple negative breast cancer (TNBC) with Dr. Stephen Chia. We cover:

    • The use of immunotherapies to treat TNBC
    • Biomarkers that can determine which patients will best respond to immunotherapies
    • The challenges of testing for PDL-1


    Our Guest:
    Dr. Stephen Chia is a professor in the division of medical oncology and staff medical oncologist with BC Cancer, in Vancouver. He has held many leadership roles at BC Cancer, including Head of the Division of Medical Oncology UBC, Head of the Department of Clinical Research, BC Cancer, and Chair of the BC Cancer Breast Tumour Group. He has also been the Co-Chair of the Breast Disease Site for Canadian Cancer Trials Group (CCTG). 

    This podcast episode was sponsored by Merck Canada.

    If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com

    17 min
  • Prophylaxis de la COVID-19: Protection des patients immunodéprimés - Ep5 - Introduction (Francais)

    Bienvenue à la série de fichiers balados d’IMPACT Medicom sur la vaccination contre la COVID-19. Roula Drossis est l’animatrice de l’épisode d’aujourd’hui. 

    Dans cet épisode, nous discutons de l'immunisation contre la COVID-19 et de la façon dont nous pouvons protéger nos populations les plus vulnérables qui ne sont pas en mesure de produire une réponse anticorps suffisante à la vaccination. 

     
    Notre invité:

    Notre invité à l’épisode d’aujourd’hui est le Dr Alex Carignan. Le Dr Carignan est médecin microbiologiste-infectiologue au Centre hospitalier universitaire de Sherbrooke. Il est également professeur titulaire et chercheur au département de microbiologie et d’infectiologie de l’Université de Sherbrooke. 

    This podcast episode was sponsored by AstraZeneca Canada.

    If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com

    13 min
  • Pre- and Post- COVID-19 Exposure Prophylaxis: Ep4 - Hematologic Malignancies

    In this podcast series on pre- and post- COVID-19 prophylaxis, we discuss immunization against COVID-19 and how we can protect our most vulnerable populations who are not able to mount a sufficient antibody response to vaccination. 

    In this fourth episode of the series, we discuss:

    • Response to COVID-19 vaccines in the general population
    • Response to COVID-19 vaccines in immunocompromised people
    • The impact of COVID-19 on patients with hematologic malignancies
    • The potential role of pre- and post- COVID-19 exposure prophylaxis for people with hematologic malignancies


    Our Guest:
    Our guest on today’s episode is Dr. Carolyn Owen, who is an an Associate Professor in the Division of Hematology & Hematological Malignancies at the University of Calgary. 

    This podcast episode was sponsored by AstraZeneca Canada.

    If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com

    19 min
  • Pre- and Post- COVID-19 Exposure Prophylaxis: Ep3 - A Pharmacist Perspective

    In this podcast series on pre- and post- COVID-19 prophylaxis, we discuss immunization against COVID-19 and how we can protect our most vulnerable populations who are not able to mount a sufficient antibody response to vaccination. 

    In this third episode of the series, we discuss:

    • Response to COVID-19 vaccines in the general population
    • Response to COVID-19 vaccines in immunocompromised people
    • The evolution of the pharmacist's role in immunization
    • The potential role of pre- and post- COVID-19 exposure prophylaxis for people who are immunocompromised


    Our Guest:
    Our guest is  Ajit Johal, who is a clinical instructor for the University of British Columbia Faculty of Pharmaceutical Sciences Program. Ajit has been providing immunizations and clinical education since 2012. In 2018, he started an organization called immunize.io, with a mission statement of "taking our best shot at immunizing the world". Through "immunize.io" he has worked with numerous organizations and communities to address “vaccine hesitancy” and improve access to vaccinations.

    Ajit also has his own podcast, which is available at: https://open.spotify.com/show/4BEzRqoLWLoQR5yM0pnW8I?si=Mc-5cOAjQNSjctNwTqtKmA&utm_source=copy-link 

    This podcast episode was sponsored by AstraZeneca Canada.

     If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com

    24 min

About IMPACT Medicom

From the publisher's feed

We are a medical communications company with a passion for developing high-quality content. We write & design content for healthcare professionals and patients in a variety of therapeutic…

More shows like IMPACT Medicom

The Daily by The New York Times

The Daily

112,262 Listeners